According to the NCI website, ublituximab is a chimeric recombinant IgG1 monoclonal antibody directed against human CD20 with potential antineoplastic activity. Check for active clinical trials using this agent. (NCI Thesaurus)

More Information in English:

Link to Drug Information Portal, a service of the U.S. National Library of Medicine, National Institutes of Health 
Link to National Cancer Institute

Wiki